Soren Dreier
  • Contact
    • About
  • Personal Guidance
  • Readings
    • – Reading Feedback
  • Healings
    • – Healing Feedback
  • Writings

Soren Dreier

Soren Dreier

  • Contact
    • About
  • Personal Guidance
  • Readings
    • – Reading Feedback
  • Healings
    • – Healing Feedback
  • Writings
CannabisHealthPsilocybin

DARPA Wants to Remove Hallucinatory “Side Effects” from Psychedelic Medicines

Posted on September 14, 2019 by Soren Dreier
Author: NA
September 14, 2019

A newly announced research program from DARPA is looking to remove those pesky hallucinatory side effects from novel psychedelic medicines such as MDMA and psilocybin. The program is currently calling out for research proposals investigating innovative drug treatments targeting post-traumatic stress disorder and depression that can be administered without the “unpredictable consequences” of current psychedelic medicines.

The program is called Focused Pharma, and DARPA’s program manager Tristan McClure-Begley says the goal is to understand the underlying neurochemical mechanism behind the efficacy of drugs such as MDMA and psilocybin. The end game would be a pill to treat PTSD or depression in military healthcare settings that doesn’t require subjects to undergo an acute psychedelic experience.

“Our fundamental hypothesis is that drugs with biased activation of specific signaling pathways downstream of the receptor may be sufficient to induce a therapeutic effect that is uncoupled from deleterious neurological effects,” McClure-Begley explains. “Recent advances in neurotransmitter receptor structure-guided drug design are allowing us to generate the tools we need to test that hypothesis.”

The Focused Pharma announcement is careful to not reference specific compounds, but instead mentions how, “certain Schedule 1 controlled drugs” have displayed promising results treating, “neuropsychiatric conditions such as chronic alcohol dependence, post-traumatic stress, and treatment-resistant depression following only limited doses.” It seems clear DARPA is referring to a growing body of research finding MDMA and psilocybin to be impressively effective in treating a number of mental health conditions.

DARPA’s plan is to institute several research projects to find out if the beneficial mental health improvements found in prior studies can be decoupled from the acute hallucinatory effects of these drugs. Successful research projects will get four years to develop a novel drug ready to apply for an Investigation New Drug application through the FDA and progress into human clinical trials.

Read More

DARPA Wants to Remove Hallucinatory “Side Effects” from Psychedelic Medicines was last modified: September 14th, 2019 by Soren Dreier
0 comment
previous post
Failed GM Mosquito Control Experiment Backfires
next post
Take the Autism Test

Recent Posts – Dreier

  • Karma: The Man Who Couldn’t Let Go

    November 6, 2019

Most Read This Week

  • On the Other Side of Selfish

    February 28, 2019
  • The Birth of the Spiritual Warrior

    May 31, 2019
  • Astral Spiders Looking For a Home

    November 17, 2015
  • Ancient Love

    December 29, 2017
  • Light is the Spirit – Dense is the Flesh

    January 3, 2018

Trending

  • Light is the Spirit – Dense is the Flesh

    January 3, 2018
  • What We Get Wrong About Time

    December 4, 2019
  • Mastering the Art of Getting What You Want

    December 3, 2019
  • Climate and the Money Trail

    December 4, 2019
  • Ketamine is a ‘Rapid-Fire’ Treatment for Depression?

    December 21, 2017
  • Time to Take a Chance?

    December 5, 2019

Chopra

  • Finding Your Way to Gratitude

    December 2, 2019
  • A New, Improved Reality Depends on You

    May 6, 2019
  • Trading In the Afterlife for One Life

    July 22, 2019
  • The Most Popular Model of Reality Is Wrong

    November 20, 2019
  • Three Impossible Things We Can’t Do Without

    May 21, 2019

Tales of Tao

  • Tales of Tao: Forfeiting the Chance to Become Immortal

    March 30, 2019
  • Tales of Tao: The Mule

    July 11, 2019
  • The Cosmic Now

    June 21, 2019
  • Tales of Tao: To Nobody

    March 29, 2019
  • The Mountain Deity and His Guard Wolf

    May 17, 2019

Categories

© 2019 - Soren Dreier


Back To Top